Human immunodeficiency virus treatment failure is possible even in those with low viral load, researchers in Canada say. Claudie Laprise of the University of Montreal, who worked in close collaboration with doctors from the Clinique ...
Tags: Prognosis for HIV, HIV Treatment Good, Anti-Retroviral Therapy
US-based Bruker has obtained 510(k) clearance from the US Food and Drug Administration (FDA) for its MALDI Biotyper CA system to identify Gram negative bacterial colonies cultured from human specimens. Bruker's MALDI Biotyper CA system ...
Editas Medicine, a transformative genome editing company, today announced it has secured a $43m Series A financing led by Flagship Ventures, Polaris Partners and Third Rock Ventures with participation from Partners Innovation Fund. ...
Tags: Editas Medicine, genome editing
US-based Moderna Therapeutics has announced the completion of a new financing round, raising $110m to develop messenger RNA Therapeutics. In aggregate, Moderna has secured more than $415m in financing and partnerships to date from the ...
Pathogenic bacteria already exist in even a healthy gut. But the healthy gut maintains a balance between beneficial and pathogenic bacteria of usually 80 to 85 percent beneficial to 20 or 15 percent pathogenic. This ratio is normal for a ...
Next-generation genetic sequencing, the idea of cheap and accessible testing, is one of the trendy areas in the medical device industry and a potential game-changer in the testing equipment sector. Just this week, GenapSys of Redwood ...
Hologic, a manufacturer of diagnostic and medical imaging systems, has obtained Health Canada approval for its Aptima HPV assay for use on the company's fully automated Panther system. Aptima HPV assay has been designed to detect ...
Tags: Health Canada, Aptima HPV Assay
NanoString Technologies, a provider of life science tools for translational research and molecular diagnostic products, has announced the availability of the nCounter Dx analysis system for high-complexity, CLIA-certified laboratories. ...
Tags: NanoString, DX Analysis System
AstraZeneca has selected an undisclosed oncology target from Regulus Therapeutics as part of their strategic alliance in order to discover, develop and commercialize microRNA therapeutics. Both the companies have entered into a strategic ...
Myriad Genetics, a US-based molecular diagnostic company, has launched a new prognostic test, Myriad myPlan Lung Cancer, for patients diagnosed with early-stage lung adenocarcinoma. myPlan lung cancer test is an RNA expression panel of 31 ...
Clontech Laboratories, a wholly-owned subsidiary of Takara Bio, announced the launch of the SMARTer Stranded RNA-Seq kit for strand-specific RNA-Seq from low-input RNA samples. The SMARTer Stranded RNA-Seq kit combines Clontech ...
Tags: Clontech Laboratories, RNA-Seq Kit
The University of Michigan’s Department of Pathology MLabs has announced the commercial availability of Mi-prostate score (MiPS) test for men, a new urine test that measures minute fragments of RNA in prostate cancer. The test ...
Tags: Prostate Cancer, Medicine
Germany-based clinical stage biopharmaceutical firm CureVac has entered into collaboration and licensing agreement with Janssen Pharmaceuticals to develop a messenger RNA (mRNA)-based influenza vaccine. The deal will see CureVac ...
Tags: Influenza Vaccine, Medicine
GIANT PANDAS are well known for being rather different from other bears. Having a diet composed almost entirely of bamboo is one of the things that sets them apart. It is also what attracted the interest of Ashli Brown of Mississippi State ...
Tags: Power-Microbes, Chemicals
US-based biotechnology company Veritas Bio received a patent related to in vivo delivery of nucleic acids from the European Patent Office. Inventor Dr Pachuk noted the allowed claims cover transfecting nucleic acids into skin or muscle ...